Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -7.10%293.3B | 4.81%1.01T | 24.72%315.72B | 2.96%967.69B | 0.09%241.23B | -1.25%221.22B | 8.97%252.11B | 3.95%253.14B | 0.05%939.9B | 6.64%241.02B |
| Cost of revenue | -13.35%173.66B | 4.35%662.96B | 26.01%200.4B | 1.58%635.34B | -3.82%167.79B | 0.26%147.13B | 8.22%161.4B | 2.52%159.03B | -1.81%625.45B | 4.69%174.46B |
| Gross profit | 3.76%119.65B | 5.70%351.28B | 22.54%115.32B | 5.69%332.35B | 10.34%73.45B | -4.12%74.09B | 10.34%90.71B | 6.45%94.11B | 3.97%314.45B | 12.11%66.56B |
| Operating expense | 3.84%17.86B | 2.68%79.76B | 7.77%17.19B | 6.16%77.68B | 2.57%22.78B | 8.33%19.86B | 7.08%19.09B | 7.75%15.96B | 6.74%73.18B | 15.32%22.21B |
| Staff costs | --8.12B | 3.26%36.83B | ---- | 2.43%35.67B | -10.74%9.75B | 12.54%10.44B | 8.23%8.9B | 2.80%6.58B | 9.11%34.82B | 13.97%10.92B |
| Selling and administrative expenses | --2.09B | -6.52%8.75B | ---- | 1.92%9.36B | -4.13%2.76B | -0.10%1.94B | -10.08%2.13B | 26.99%2.52B | 0.20%9.18B | 0.91%2.88B |
| -Selling and marketing expense | --2.09B | -6.52%8.75B | ---- | 1.92%9.36B | -4.13%2.76B | -0.10%1.94B | -10.08%2.13B | 26.99%2.52B | 0.20%9.18B | 0.91%2.88B |
| Other operating expenses | --7.65B | 4.68%34.18B | ---- | 11.94%32.66B | 22.15%10.27B | 5.13%7.48B | 11.40%8.05B | 6.72%6.86B | 6.16%29.17B | 23.26%8.41B |
| Operating profit | 3.74%101.79B | 6.62%271.52B | 25.55%98.12B | 5.55%254.67B | 14.23%50.67B | -8.00%54.22B | 11.24%71.63B | 6.19%78.15B | 3.16%241.28B | 10.57%44.36B |
| Net non-operating interest income (expenses) | -34.41%3.59B | -15.71%-19.28B | 13.89%5.48B | 2.70%-16.66B | -16.90%-22.34B | 131.32%4.28B | -1.94%-3.42B | 37.98%4.81B | 4.36%-17.12B | -16.45%-19.11B |
| Non-operating interest income | -2.33%10.01B | -13.84%1.12B | 9.73%10.24B | 186.56%1.3B | -21.22%-17.89B | 36.32%8.69B | 11.52%1.16B | 19.80%9.34B | 249.23%454M | -22.79%-14.76B |
| Non-operating interest expense | 34.54%6.41B | 13.57%20.4B | 5.30%4.77B | 2.19%17.96B | 2.23%4.45B | -2.56%4.41B | 4.21%4.58B | 5.08%4.53B | -2.53%17.58B | -0.89%4.35B |
| Net investment income | 1.90%19.3B | 21.18%18.94B | 23.41%15.63B | |||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 216.62%5.13B | 338.73%38.3B | 1.62B | 94.35%8.73B | 94.11%8.74B | -3,942.86%-283M | -4.86%274M | 0 | 255.10%4.49B | 156.67%4.5B |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -1,256.10%-4.67B | -282.18%-32.78B | -86.96%-344M | 20.62%-8.58B | 3.77%-9.08B | -25.40%-711M | 331.57%1.4B | 5.15%-184M | -39.88%-10.81B | -327.54%-9.44B |
| Less:Other special charges | 1,256.10%4.67B | 788.99%14.05B | 86.96%344M | -41.63%1.58B | 55.56%2.09B | 25.40%711M | -331.57%-1.4B | -5.15%184M | -36.63%2.71B | -25.83%1.34B |
| Less:Write off | ---- | 167.75%18.74B | ---- | -13.59%7B | ---- | ---- | ---- | ---- | 134.55%8.1B | ---- |
| Other non-operating income (expenses) | 75.44%-140M | 16.21%-3.21B | 35.96%-570M | -22.52%-3.83B | -83.79%-1.53B | -9.98%-716M | 16.00%-693M | -8.94%-890M | 11.34%-3.13B | 46.05%-833M |
| Income before tax | 1.34%105.71B | 8.12%273.84B | 27.38%104.31B | 9.95%253.26B | 29.32%45.39B | -4.64%56.8B | 15.51%69.19B | 8.06%81.89B | 5.34%230.34B | 2.12%35.1B |
| Income tax | 7.26%31.93B | 7.97%82.16B | 19.03%29.77B | 11.23%76.09B | 57.35%13.81B | -4.89%17.13B | 7.51%20.15B | 9.27%25.01B | 0.31%68.41B | -32.06%8.78B |
| Net income | -1.02%73.78B | 8.19%191.68B | 31.05%74.54B | 9.42%177.17B | 19.98%31.58B | -4.54%39.67B | 19.15%49.04B | 7.54%56.88B | 7.63%161.93B | 22.70%26.32B |
| Net income continuous operations | -1.02%73.78B | 8.19%191.68B | 31.05%74.54B | 9.41%177.17B | 19.97%31.58B | -4.54%39.67B | 19.15%49.04B | 7.54%56.88B | 7.63%161.93B | 22.71%26.32B |
| Noncontrolling interests | 0 | 0 | 0 | |||||||
| Net income attributable to the company | -1.02%73.78B | 8.19%191.68B | 31.05%74.54B | 9.42%177.17B | 19.98%31.58B | -4.54%39.67B | 19.15%49.04B | 7.54%56.88B | 7.63%161.93B | 22.70%26.32B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -1.02%73.78B | 8.19%191.68B | 31.05%74.54B | 9.42%177.17B | 19.98%31.58B | -4.54%39.67B | 19.15%49.04B | 7.54%56.88B | 7.63%161.93B | 22.70%26.32B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 0.40%78.955 | 8.37%202.555 | 31.04%78.64 | 9.42%186.915 | 19.97%33.315 | -4.53%41.85 | 19.15%51.74 | 7.54%60.01 | 7.63%170.83 | 22.71%27.77 |
| Diluted earnings per share | 0.40%78.955 | 8.37%202.555 | 31.04%78.64 | 9.42%186.915 | 19.98%33.315 | -4.53%41.8493 | 19.15%51.74 | 7.54%60.01 | 7.63%170.83 | 22.70%27.7673 |
| Dividend per share | 0 | 16.67%35 | 0 | 15.38%30 | 10.71%15.5 | 0 | 20.83%14.5 | 0 | 15.56%26 | 21.74%14 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |